Drug maker Astrazeneca announcing today its vaccine candidate was up to 90 percent effective in large-scale trials.
HER WORLD...AND EXPLAINS WHY THEABUSE MAY NOT ALWAYS LOOK THEWAY YOU THINK IT DOES....THERE ARE NOW THREE VACCINESWAITING FOR F-D-A APPROVAL ..DRUG MAKER ASTRAZENECAANNOUNCING TODAY ITS VACCINECANDIDATE WAS UP TO 90 PERCENTEFFECTIVE IN LARGE-SCALE TRIALS.IT’S THE THIRD VACCINE TO REACHTHAT POINT - BUT UNLIKE THE ONESMADE BY COMPETITORS PFIZER ANDMODERNA....ASTRAZENECA’SCANDIDATE DOES NOT NEED TO BESTORED IN SPECIALTY FREEZERS.IT’S ALSO SIGNIFICANTLY LESSEXPENSIVE.
THE NEXT STEP ISREGULATORY APPROVAL - WHICHCOULD COME IN AS LITTLE AS THREEWEEKS."We have to vaccinate seventypercent to bring it up to alevel where it really slows itdown....We will be able toaccomplish this with thesevaccines."F-D-A OFFICIALS WILL BEMEETING ON DECEMBER 10TH TOCONSIDER PFIZER’S REQUEST FOREMERGENCY USE AUTHORIZATION.AS FOR CORONAVIRUS CASES IN OURSTAT
[NFA] Moderna will apply for U.S. and European emergency-use authorization for its COVID-19 vaccine on Monday after full results..
A COVID-19 vaccine could make its way to Indiana within the next few months.
